NYSE: CWCurtiss Wright Corp Stock
$492.15-4.64 (-0.93%)
Updated Aug 14, 2025
CW Price
$492.15
Fair Value Price
N/A
Market Cap
$18.54B
52 Week Low
$266.88
52 Week High
$517.09
P/E
41.32x
P/B
6.84x
P/S
5.57x
PEG
4.85x
Dividend Yield
0.18%
Revenue
$3.31B
Earnings
$451.41M
Gross Margin
37.3%
Operating Margin
18.83%
Profit Margin
13.7%
Debt to Equity
0.92
Operating Cash Flow
$576M
Beta
0.92
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CW Overview
Curtiss-Wright Corporation manufactures aircraft-related components (actuators, aircraft controls, valves, and surface technology services, including shot peening, laser peening, and coatings). It also supplies commercial, industrial, defense, and energy markets (parts for commercial and naval nuclear power systems, industrial vehicles, and oil- and gas-related machinery). Formed in 1929, the company is headquartered in Parsippany-Troy Hills, NJ.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CW's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important CW news, forecast changes, insider trades & much more!
CW News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CW scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CW ($492.15) is trading above its intrinsic value of $105.71, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CW is poor value based on its earnings relative to its share price (41.32x), compared to the US market average (36.29x)
P/E vs Market Valuation
CW is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CW due diligence checks available for Premium users.
Valuation
CW price to earnings (PE)
For valuing profitable companies with steady earnings
Company
41.32x
Industry
37.79x
Market
36.29x
CW is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CW is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
CW price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
6.84x
Industry
6.71x
CW is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CW price to earnings growth (PEG)
For valuing profitable companies with growth potential
CW is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
CW's financial health
Profit margin
Revenue
$876.6M
Net Income
$121.1M
Profit Margin
13.8%
CW's Earnings (EBIT) of $622.42M... subscribe to Premium to read more.
Interest Coverage Financials
CW's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$5.2B
Liabilities
$2.5B
Debt to equity
0.92
CW's short-term assets ($2.00B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CW's short-term assets ($2.00B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CW's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CW's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$136.6M
Investing
-$11.7M
Financing
-$29.1M
CW's operating cash flow ($576.39M)... subscribe to Premium to read more.
Debt Coverage Financials
CW vs Defense Stocks
Curtiss Wright Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.